SHAREHOLDER ALERT: Axsome Therapeutics, Inc. (AXSM) Officers and Directors Face Shareholder Investigation for Alleged Securities Law Violations

SAN FRANCISCO, March 14, 2023 /PRNewswire/ — Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM) relating to securities law violations and unlawful business practices. Axsome Therapeutics is a…

Leave a Reply

Your email address will not be published. Required fields are marked *